These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12889083)

  • 1. Altered corticomotor representation in patients with Parkinson's disease.
    Kagerer FA; Summers JJ; Byblow WD; Taylor B
    Mov Disord; 2003 Aug; 18(8):919-27. PubMed ID: 12889083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
    Buhmann C; Gorsler A; Bäumer T; Hidding U; Demiralay C; Hinkelmann K; Weiller C; Siebner HR; Münchau A
    Brain; 2004 Dec; 127(Pt 12):2732-46. PubMed ID: 15509619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms underlying mirror movements in Parkinson's disease: a transcranial magnetic stimulation study.
    Cincotta M; Borgheresi A; Balestrieri F; Giovannelli F; Ragazzoni A; Vanni P; Benvenuti F; Zaccara G; Ziemann U
    Mov Disord; 2006 Jul; 21(7):1019-25. PubMed ID: 16547917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
    Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric corticomotor excitability correlations in early Parkinson's disease.
    Wu AD; Petzinger GM; Lin CH; Kung M; Fisher B
    Mov Disord; 2007 Aug; 22(11):1587-93. PubMed ID: 17523196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor cortex reorganisation in Parkinson's disease.
    Thickbroom GW; Byrnes ML; Walters S; Stell R; Mastaglia FL
    J Clin Neurosci; 2006 Jul; 13(6):639-42. PubMed ID: 16814549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive magnetic stimulation of cortical motor areas in Parkinson's disease: implications for the pathophysiology of cortical function.
    Gilio F; Currà A; Inghilleri M; Lorenzano C; Manfredi M; Berardelli A
    Mov Disord; 2002 May; 17(3):467-73. PubMed ID: 12112192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of central motor functions using magnetic stimulation in Parkinson's disease.
    Diószeghy P; Hidasi E; Mechler F
    Electromyogr Clin Neurophysiol; 1999 Mar; 39(2):101-5. PubMed ID: 10207679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of the TMS in the early stages of Parkinson's disease.
    Guekht A; Selikhova M; Serkin G; Gusev E
    Electromyogr Clin Neurophysiol; 2005; 45(5):291-7. PubMed ID: 16218197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical inhibition in Parkinson's disease: new insights from early, untreated patients.
    Cantello R; Tarletti R; Varrasi C; Cecchin M; Monaco F
    Neuroscience; 2007 Nov; 150(1):64-71. PubMed ID: 17964730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic drugs restore facilitatory premotor-motor interactions in Parkinson disease.
    Mir P; Matsunaga K; Gilio F; Quinn NP; Siebner HR; Rothwell JC
    Neurology; 2005 Jun; 64(11):1906-12. PubMed ID: 15955942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short and long latency afferent inhibition in Parkinson's disease.
    Sailer A; Molnar GF; Paradiso G; Gunraj CA; Lang AE; Chen R
    Brain; 2003 Aug; 126(Pt 8):1883-94. PubMed ID: 12805105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation.
    Lefaucheur JP
    Clin Neurophysiol; 2005 Feb; 116(2):244-53. PubMed ID: 15661100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: evidence from transcranial magnetic stimulation.
    Rodrigues JP; Walters SE; Stell R; Mastaglia FL; Thickbroom GW
    Neurosci Lett; 2008 Dec; 448(1):29-32. PubMed ID: 18952149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of central motor abnormalities in amyotrophic lateral sclerosis.
    Mills KR
    Brain; 2003 Nov; 126(Pt 11):2558-66. PubMed ID: 12937082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled study of rTMS for the treatment of Parkinson's disease.
    Lomarev MP; Kanchana S; Bara-Jimenez W; Iyer M; Wassermann EM; Hallett M
    Mov Disord; 2006 Mar; 21(3):325-31. PubMed ID: 16211618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for excitability changes in human primary motor cortex during ipsilateral voluntary contractions.
    Liang N; Murakami T; Funase K; Narita T; Kasai T
    Neurosci Lett; 2008 Mar; 433(2):135-40. PubMed ID: 18261851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional connectivity in human cortical motor system: a cortico-cortical evoked potential study.
    Matsumoto R; Nair DR; LaPresto E; Bingaman W; Shibasaki H; Lüders HO
    Brain; 2007 Jan; 130(Pt 1):181-97. PubMed ID: 17046857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional changes in the activity of cerebellum and frontostriatal regions during externally and internally timed movement in Parkinson's disease.
    Cerasa A; Hagberg GE; Peppe A; Bianciardi M; Gioia MC; Costa A; Castriota-Scanderbeg A; Caltagirone C; Sabatini U
    Brain Res Bull; 2006 Dec; 71(1-3):259-69. PubMed ID: 17113955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.